Phoenix Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,868
Closed -$2.48M 129
2025
Q4
$2.48M Sell
25,868
-482
-2% -$46.8K 0.96% 27
2025
Q3
$2.51M Sell
26,350
-902
-3% -$82.9K 0.96% 29
2025
Q2
$2.38M Sell
27,252
-1,072
-4% -$90.9K 0.99% 34
2025
Q1
$2.55M Sell
28,324
-279
-1% -$25K 1.11% 30
2024
Q4
$2.28M Sell
28,603
-1,274
-4% -$110K 0.99% 34
2024
Q3
$2.69M Sell
29,877
-293
-1% -$24.6K 1.25% 27
2024
Q2
$2.37M Buy
30,170
+362
+1% +$29.7K 1.19% 27
2024
Q1
$2.6M Buy
29,808
+792
+3% +$67.6K 1.58% 25
2023
Q4
$2.4M Sell
29,016
-2,176
-7% -$166K 1.67% 24
2023
Q3
$2.44M Buy
31,192
+803
+3% +$67.2K 1.44% 17
2023
Q2
$2.68M Sell
30,389
-490
-2% -$42.2K 1.56% 15
2023
Q1
$2.49M Buy
+30,879
New +$2.52M 1.54% 19
2022
Q3
Sell
-8,179
Closed -$734K 117
2022
Q2
$734K Buy
+8,179
New +$829K 0.72% 34
2022
Q1
Sell
-5,301
Closed -$548K 116
2021
Q4
$548K Buy
5,301
+2,581
+95% +$299K 0.41% 58
2021
Q3
$341K Buy
2,720
+85
+3% +$11K 0.25% 82
2021
Q2
$335K Buy
2,635
+212
+9% +$26.6K 0.24% 88
2021
Q1
$286K Buy
2,423
+546
+29% +$64K 0.22% 85
2020
Q4
$220K Buy
+1,877
New +$207K 0.17% 104

Other funds holding MDT

Phoenix Wealth Advisors's MDT Position: Q1 2026 in Review

Phoenix Wealth Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 25,868 shares — an estimated $2.48M sold.

Phoenix Wealth Advisors first reported a position in MDT in Q4 2020 and held it in 18 quarters. The position peaked at $2.69M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Phoenix Wealth Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Phoenix Wealth Advisors sold 25,868 Medtronic shares in Q1 2026, an estimated $2.48M.
  • Phoenix Wealth Advisors first reported a position in Medtronic in Q4 2020 and held it in 18 quarters.
  • Phoenix Wealth Advisors's Medtronic position peaked at $2.69M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Phoenix Wealth Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.